Created in 1987 (United States), EpiTherapeutics own 32 sister brands and 17477 competing brands. The EpiTherapeutics brand is owned by Gilead Sciences, a company listed in New York. EpiTherapeutics is part of the Drug Manufacturers activity sector.

EpiTherapeutics is a brand of Gilead Sciences (GILD) Share price

Share price and profitability of the share Gilead Sciences (EpiTherapeutics)

Buy Gilead Sciences share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 66.16

Portfolio valuation
Gilead Sciences (EpiTherapeutics) over 5 years* USD 70.08

Stock market history Gilead Sciences (EpiTherapeutics)

Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more